Source link : https://newshealth.biz/health-news/t-cell-killer-opens-new-approach-to-rheumatoid-arthritis/
(MedPage Today) — CHICAGO — An investigational monoclonal antibody drug targeting the PD-1 ligand on T cells was a winner in a phase II rheumatoid arthritis (RA) trial. Twelve weeks of treatment with the agent, called rosnilimab, led to a… Source link : https://www.medpagetoday.com/meetingcoverage/acr/118229 Author : Publish date : 2025-10-30 15:22:00 Copyright for syndicated content […]
The post T-Cell Killer Opens New Approach to Rheumatoid Arthritis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-30 15:22:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8